Mymetics Corp (MYMX) - Strategic SWOT Analysis Review

August 2020 | 28 pages | ID: M57FE00A849EN
GlobalData

Abstracts

Mymetics Corp (MYMX) - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.

This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

• Business description – A detailed description of the company’s operations and business divisions.
• Corporate strategy – GlobalData’s summarization of the company’s business strategy.
• SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
• Company history – Progression of key events associated with the company.
• Major products and services – A list of major products, services and brands of the company.
• Key competitors – A list of key competitors to the company.
• Key employees – A list of the key executives of the company.
• Executive biographies – A brief summary of the executives’ employment history.
• Key operational heads – A list of personnel heading key departments/functions.
• Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.

Highlights

Mymetics Corp (Mymetics) is a biotechnology company that develops next-generation prophylactic vaccines for infectious diseases. The company develops pipeline products based on its proprietary technology platform virosomes with the utilization of rationally designed antigens, natural membrane proteins and lipid based carrier with fusion viral proteins. Its pipeline product includes vaccine candidates that target HIV-1/AIDS, chikungunya, intra nasal influenza, malaria, herpes simplex virus (HSV) and respiratory syncytial virus (RSV). Mymetics vaccines are designed for protection against early transmission and infection. The company has subsidiaries in the Netherlands and Switzerland. Mymetics is headquartered in Epalinges, Lausanne, Switzerland.

Mymetics Corp Key Recent Developments

Apr 29,2019: Mymetics receives funding from NIH for novel HIV vaccine study
Apr 29,2019: Mymetics receives HIV Vaccine Funding from the NIH
Jan 22,2019: Successful completion of EU Horizon 2020 Grant MACIVIVA

Reasons to Buy

• Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
• Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
• Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
• Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

Contents

SECTION 1 - ABOUT THE COMPANY

Mymetics Corp - Key Facts
Mymetics Corp - Key Employees
Mymetics Corp - Key Employee Biographies
Mymetics Corp - Major Products and Services
Mymetics Corp - History
Mymetics Corp - Company Statement
Mymetics Corp - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries

SECTION 2 – COMPANY ANALYSIS

Company Overview
Mymetics Corp - Business Description
R&D Overview
Mymetics Corp - Corporate Strategy
Mymetics Corp - SWOT Analysis
SWOT Analysis - Overview
Mymetics Corp - Strengths
Mymetics Corp - Weaknesses
Mymetics Corp - Opportunities
Mymetics Corp - Threats
Mymetics Corp - Key Competitors

SECTION 3 – COMPANY’S LIFESCIENCES FINANCIAL DEALS AND ALLIANCES

Mymetics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Mymetics Corp, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Mymetics Corp, Recent Deals Summary

SECTION 4 – COMPANY’S RECENT DEVELOPMENTS

Apr 29, 2019: Mymetics receives funding from NIH for novel HIV vaccine study
Apr 29, 2019: Mymetics receives HIV Vaccine Funding from the NIH
Jan 22, 2019: Successful completion of EU Horizon 2020 Grant MACIVIVA

SECTION 5 – APPENDIX

Methodology
About GlobalData
Contact Us
Disclaimer

List Of Tables

LIST OF TABLES

Mymetics Corp, Key Facts
Mymetics Corp, Key Employees
Mymetics Corp, Key Employee Biographies
Mymetics Corp, Major Products and Services
Mymetics Corp, History
Mymetics Corp, Subsidiaries
Mymetics Corp, Key Competitors
Mymetics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Mymetics Corp, Pharmaceuticals & Healthcare, Deals By Type, 2014 to YTD 2020
Mymetics Corp, Recent Deals Summary

List Of Figures

LIST OF FIGURES

Mymetics Corp, Pharmaceuticals & Healthcare, Deals By Year, 2014 to YTD 2020
Mymetics Corp, Pharmaceuticals & Healthcare, Deals by Type, 2014 to YTD 2020

COMPANIES MENTIONED

Seqirus Inc
Sanofi Pasteur SA
PaxVax Inc
Novavax Inc
Merck & Co Inc
GlaxoSmithKline Plc
Crucell Holland BV